Elbow
Implant survival after total elbow arthroplasty: a retrospective study of 324 procedures performed from 1980 to 2008

https://doi.org/10.1016/j.jse.2014.02.001Get rights and content

Background

Total elbow arthroplasty (TEA) is an established treatment for late-stage arthritis of the elbow. Indications have expanded to osteoarthritis and nonunion in distal humeral fractures. Information on implant survival and risk factors for revision is still sparse. The aim of this study was to evaluate implant survival and risk factors for revision of TEAs inserted in patients in the eastern part of Denmark in the period from 1980 until 2008.

Material and methods

The Danish National Patient Register provided personal identification numbers for patients who underwent TEA procedures from 1980 until 2008. On the basis of a review of medical reports and linkage to the National Patient Register, we calculated revision rates and evaluated potential risk factors for revision, including, age, sex, period, indication for TEA, and implant design.

Results

We evaluated 324 primary TEA procedures in 234 patients at a mean follow-up of 8.7 years (range, 0-27 years). The overall 5-year survival was 90% (95% confidence interval [CI], 88%-94%), and 10-year survival was 81% (95% CI, 76%-86%). TEAs performed with the unlinked design had a relative risk of revision of 1.9 (95% CI, 1.1-3.2) compared with the linked design. Fracture sequelae was associated with a relative risk of revision of 1.9 (95% CI, 1.05-3.45).

Conclusions

We found acceptable implant survival rates after 5 and 10 years, with a higher revision rate for the unlinked design and primary TEA due to fracture sequelae. Patient-related outcome measures should be included in future studies for further elaboration of the outcomes after TEA.

Section snippets

Material and methods

This study was based on data provided by the Danish National Patient Register (NPR) for patients who underwent TEA procedures in eastern part of Denmark between 1980 and 2008.

Statistics

The end point for survival was defined as revision involving 1 component or the entire implant (removal or exchange). All patients were followed up from surgery to revision, death, emigration, or January 1, 2013. Kaplan-Meier survival analyses were used to calculate implant survival rates at 1, 5, 10, and 15 years. Survival data obtained in the Kaplan-Meier analysis were compared by the log-rank test (Mantel-Cox). The TEA was bilateral in 45 patients, and each replacement procedure was

Patient characteristics

Of the 324 TEA operations, 264 (81.5%) were performed in women. At the time of primary TEA, the mean age was 62 years (range, 25-91 years), and 160 (49.4%) of the TEAs were performed on the right elbow. Rheumatoid arthritis (RA) was the most frequent indication for the TEA operation, with 237 (73.1%) procedures performed. Other indications for primary TEA were fracture sequelae with 61 procedures, including 7 acute fractures (18.8%), osteoarthritis (OA) in 18 (5.6%), and other indications,

Discussion

In this retrospective study we found acceptable 5-, 10-, and 15-year implant survival rates after primary TEA. Patients receiving TEAs over time have increased, and since 2003, the choice of implant has been dominated by the linked design. Revision rates and RR estimates were higher for the unlinked design. The most common reason for revision for both the linked and unlinked design was aseptic loosening. TEA procedures performed due to fracture and fracture sequelae were associated with

Conclusions

Survival analysis on TEA is sparse as are studies comparing TEA designs. RA continues to be the most common indication, but TEA procedures due to fracture and fracture sequelae are increasing, with a higher risk for revision. The survival rates of revision TEAs are promising, which is of interest when performing primary TEA surgery on younger patients, who are more likely than older patients to live past the survival of their primary TEA. The tendency goes toward the linked design, which in

Disclaimer

The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article.

References (24)

  • M.P. Espag et al.

    Early results of the Souter-Strathclyde unlinked total elbow arthroplasty in patients with osteoarthritis

    J Bone Joint Surg Br

    (2003)
  • G. Giannicola et al.

    Radial head, radiocapitellar and total elbow arthroplasties: a review of recent literature

    Injury

    (2013)
  • Cited by (85)

    • Intraoperative modification of total elbow arthroplasty implants

      2023, Journal of Shoulder and Elbow Surgery
    • Testing of Novel Total Elbow Prostheses Using Active Motion Experimental Setup

      2023, Journal of Hand Surgery
      Citation Excerpt :

      We are testing this novel total elbow arthroplasty (TEA) in different degrees of abduction because in the dependent position the elbow does not experience substantial varus or valgus laxity and total elbow arthroplasty designs do not reach the laxity limits of the linkage mechanism.5,14,15 Our experimental setup aims to reproduce the in vivo situation by abducting and adducting the arm and recreating varus and valgus forces, which have been implicated in the creation of polyethylene edge loading that is identified in explanted, semiconstrained total elbow replacement bearings (Fig. 6).16–19 This experimental setup reproduces active muscle forces that both move and dynamically stabilize the elbow and can offload the stabilizing ligaments by increasing osseous stability.20

    View all citing articles on Scopus

    The Scientific Ethics Committee for the Hovedstaden Region approved this study.

    View full text